Lancet
The most recent articles from:
Lancet
-
Randomized Controlled Trial Multicenter Study Clinical Trial
Post-malaria neurological syndrome.
Neurological signs and symptoms are common in malaria, but observations in Vietnam and Thailand have pointed to a discrete transient neurological syndrome after recovery from severe infections. ⋯ Mefloquine is not the only risk factor for PMNS but it is a strong one. Where an effective alternative drug is available, mefloquine should not be used after treatment of severe malaria.
-
Comment Letter Comparative Study Clinical Trial Controlled Clinical Trial
High-dose inhaled steroids in asthmatic children.